In the original version of the article, a correction in Table 2 was inadvertently missed. The text for the ACIDFORM gel previously read as “13.7% [42] (n=1183) (7-cycle cumulative typical-use pregnancy rate or Food and Drug Administration (FDA) reviewed. Amphora was applied 0–60 min before coitus.)”. However, the correct text is “13.7% [42] (n=1183) (7-cycle cumulative typical-use pregnancy rate). Amphora was applied 0–60 min before coitus”. The correct version of Table 2 appears online now. The publisher apologizes for this error.
. 2020 Sep 2;103(4):908. doi: 10.1093/biolre/ioaa148
Erratum to ‘The postcoital test in the development of new vaginal contraceptives’
Christine K Mauck
1,✉, Kathleen L Vincent
2
Kathleen L Vincent
2
Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, TX, USA
Find articles by Kathleen L Vincent
1
Daré Bioscience Inc., San Diego, CA, USA
2
Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, TX, USA
✉
Correspondence: Daré Bioscience Inc., San Diego, CA, USA. Tel: 301-325-5439; E-mail: cmauck@darebioscience.com
Received 2020 Feb 4; Revised 2020 May 21; Accepted 2020 Jun 12; Collection date 2020 Oct.
© The Author(s) 2020. Published by Oxford University Press on behalf of Society for the Study of Reproduction. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
PMCID: PMC7569348 PMID: 32876665
This corrects the article "The postcoital test in the development of new vaginal contraceptives" on page 437.
